SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis, 2025, Moreau, Fluge, Mella et al

yeah looks dodgy as heck. that’s the first post I get for opening twitter out of curiosity to see how different it is now that i’ve spent the past yearish on bluesky ahah. Not impressed.
 
One thing as an engineer that bugs me is this guy Jack markets himself as “ex-aerospace engineer” has never worked in industry, might have a degree but that essentially it. That’s a red flag to begin with for me, selling himself way bigger, reminds me of Silicon Valley hype.

Second they don’t screen for ME/CFS CCC and sell the test to anyone so even if their tests were reliable who knows what they are screening
 
You must log in or register to reply here.
Back
Top Bottom